These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
502 related items for PubMed ID: 28357778
21. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Thompson HS, Valdimarsdottir HB, Duteau-Buck C, Guevarra J, Bovbjerg DH, Richmond-Avellaneda C, Amarel D, Godfrey D, Brown K, Offit K. Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047 [Abstract] [Full Text] [Related]
22. Economic impact of multigene panel testing for hereditary breast and ovarian cancer. Byfield SD, Wei H, DuCharme M, Lancaster JM. J Comp Eff Res; 2021 Feb; 10(3):207-217. PubMed ID: 33491479 [Abstract] [Full Text] [Related]
25. The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program. Bunnell AE, Garby CA, Pearson EJ, Walker SA, Panos LE, Blum JL. J Genet Couns; 2017 Feb; 26(1):105-112. PubMed ID: 27276934 [Abstract] [Full Text] [Related]
27. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling. Høberg-Vetti H, Eide GE, Siglen E, Listøl W, Haavind MT, Hoogerbrugge N, Bjorvatn C. Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464 [Abstract] [Full Text] [Related]
32. Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations. Underhill-Blazey M, Blonquist T, Chittenden A, Pozzar R, Nayak M, Lansang K, Hong F, Garber J, Stopfer JE. J Genet Couns; 2021 Feb 15; 30(1):268-282. PubMed ID: 32851753 [Abstract] [Full Text] [Related]
33. Impact of BRCA1 testing on women with cancer: a pilot study. Wood ME, Mullineaux L, Rahm AK, Fairclough D, Wenzel L. Genet Test; 2000 Feb 15; 4(3):265-72. PubMed ID: 11142757 [Abstract] [Full Text] [Related]
35. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S. J Natl Compr Canc Netw; 2016 Feb 15; 14(2):153-62. PubMed ID: 26850485 [Abstract] [Full Text] [Related]
36. Impact of Implementing B-RSTTM to Screen for Hereditary Breast and Ovarian Cancer on Risk Perception and Genetic Counseling Uptake Among Women in an Academic Safety Net Hospital. Wernke K, Bellcross C, Gabram S, Ali N, Stanislaw C. Clin Breast Cancer; 2019 Aug 15; 19(4):e547-e555. PubMed ID: 31005475 [Abstract] [Full Text] [Related]